SBRNA
Live / Applied — Third extension granted (statement of use) (as of 07 Nov 2025)
What this means for you
Not registered yet, but its 08 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97709367
- Mark type
- Stylized text
- Filed
- 08 Dec 2022
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Syed Abedi
Goods and services
- Class 001 — Chemicals: Clinical preparations in the nature of chemicals and biochemicals for use in the manufacture of medical preparations for treatment of genetic diseases
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines for genetic diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases
Owner
- Iris Medicine, Inc., Berkeley, CA, US
- Iris Medicine, Inc., Berkeley, CA, US
Prosecution history
- 08 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2025 — SOU EXTENSION 3 GRANTED
- 07 Nov 2025 — SOU EXTENSION 3 FILED
- 07 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2025 — SOU EXTENSION 2 GRANTED
- 29 Apr 2025 — SOU EXTENSION 2 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2024 — SOU EXTENSION 1 GRANTED
- 06 Nov 2024 — SOU EXTENSION 1 FILED
- 06 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION